Partners L P/il Bvf's Net Worth
$3.89 Billion
Who is Partners L P/il Bvf?
Partners L P/il Bvf has an estimated net worth of $3.89 Billion. This is based on reported shares across multiple companies, which include Allakos Inc., Rain Oncology Inc., ARENA PHARMACEUTICALS INC, IMMUNE DESIGN CORP., Cascadian Therapeutics, Inc., Capstone Therapeutics Corp., ChemoCentryx, Inc., DYNAVAX TECHNOLOGIES CORP, REPLIGEN CORP, KENT INTERNATIONAL HOLDINGS INC, NEUROCRINE BIOSCIENCES INC, XOMA Corp, LIGAND PHARMACEUTICALS INC, RIGEL PHARMACEUTICALS INC, Xenon Pharmaceuticals Inc., Cullinan Oncology, Inc., Merus N.V., Nivalis Therapeutics, Inc., Repare Therapeutics Inc., PIERIS PHARMACEUTICALS, INC., Verastem, Inc., Syndax Pharmaceuticals Inc, CTI BIOPHARMA CORP, IDEAYA Biosciences, Inc., CYTOKINETICS INC, Kymera Therapeutics, Inc., CURIS INC, Calithera Biosciences, Inc., CONCERT PHARMACEUTICALS, INC., PALATIN TECHNOLOGIES INC, MEDICINOVA INC, CATALYST BIOSCIENCES, INC., CytomX Therapeutics, Inc., MoonLake Immunotherapeutics, GLYCOMIMETICS INC, Principia Biopharma Inc., INFINITY PHARMACEUTICALS, INC., Eledon Pharmaceuticals, Inc., Olema Pharmaceuticals, Inc., Regulus Therapeutics Inc., ADVANCED MAGNETICS INC, ESSA Pharma Inc., 4D Molecular Therapeutics, Inc., NPS PHARMACEUTICALS INC, ICAGEN INC, ADOLOR CORP, Third Harmonic Bio, Inc., ZONAGEN INC, COMBINATORX, INC, Regado Biosciences Inc, SUPERGEN INC, FIVE PRIME THERAPEUTICS, INC., Structure Therapeutics Inc., ARRAY BIOPHARMA INC, ARQULE INC, AEOLUS PHARMACEUTICALS, INC., INHIBITEX, INC., NEUROBIOLOGICAL TECHNOLOGIES INC /CA/, enGene Holdings Inc., Celera CORP, FACET BIOTECH CORP, PHARMACOPEIA INC, AVIGEN INC \DE, SGX PHARMACEUTICALS, INC., VIACELL INC, NEUROGEN CORP, POINT Biopharma Global Inc., GENAERA CORP, AEROGEN INC, CORVAS INTERNATIONAL INC, BIOCRYST PHARMACEUTICALS INC, and APPLIED MOLECULAR EVOLUTION INC.
SEC CIK
Partners L P/il Bvf's CIK is 0001055947
Past Insider Trading and Trends
2008 was Partners L P/il Bvf's most active year for acquiring shares with 351 total transactions. Partners L P/il Bvf's most active month to acquire stocks was the month of October. 2009 was Partners L P/il Bvf's most active year for disposing of shares, totalling 86 transactions. Partners L P/il Bvf's most active month to dispose stocks was the month of May. 2021 saw Partners L P/il Bvf paying a total of $132,144,944.64 for 12,405,370 shares, this is the most they've acquired in one year. In 2020 Partners L P/il Bvf cashed out on 18,981,731.772 shares for a total of $187,629,819.78, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Allakos Inc. (ALLK) Snapshot price: $1.28
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Rain Oncology Inc. (RAIN) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -8.58M |
—
|
—
|
0
|
Jan 25 - Jan 26
| |||
Form 4
| +47.80% | 1.71M |
$5.83 | $9,971,387.14 | 5.29M |
Nov 8
| |||
Form 4
| +20.43% | 557.73K |
$12.00 | $6,692,637.85 | 3.29M |
Jan 6 - Jan 7
| |||
Form 4
| +0.41% | 11.03K |
$13.94 | $153,828.71 | 2.73M |
Sep 21
| |||
Form 4
| +16.86% | 392.27K |
$16.49 | $6,468,515.81 | 2.72M |
Sep 13
| |||
Form 4
| +33.73% | 587K |
$15.47 | $9,078,692.10 | 2.33M |
Jul 1 - Jul 6
| |||
Form 4
| +7.63% | 123.35K |
$15.94 | $1,966,334.17 | 1.74M |
May 21 - May 24
| |||
Form 4
| +14.80% | 208.47K |
$16.59 | $3,457,720.14 | 1.62M |
May 18 - May 19
| |||
Form 4
| +4.30% | 58K |
$14.26 | $827,167.00 | 1.41M |
May 13
| |||
Form 4/A
| +522.18% | 1.13M |
$16.86 | $19,103,379.78 | 1.35M |
Apr 23 - Apr 26
| |||
Form 4
|
∞
| 4.93M |
$16.86 |
—
| 4.93M |
Apr 23 - Apr 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ARENA PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -12.32% | -828.09K |
$5.10 | -$4,219,175.99 | 5.89M |
Jul 7 - Jul 8
| |||
Form 4
| -3.35% | -95.00K |
$5.42 | -$514,900.00 | 2.74M |
Jul 1
| |||
Form 4
| -2.44% | -71.00K |
$5.31 | -$376,797.00 | 2.83M |
Jun 29
| |||
Form 4
| -0.92% | -54.00K |
$5.36 | -$287,009.90 | 5.82M |
Jun 28
| |||
Form 4
| -0.20% | -6.00K |
$5.52 | -$33,114.00 | 2.96M |
Jun 18
| |||
Form 4
| -3.39% | -104.00K |
$5.40 | -$561,600.00 | 2.97M |
Jun 16
| |||
Form 4
| -1.64% | -144.50K |
$6.00 | -$867,000.00 | 8.67M |
Jan 20 - Jan 21
| |||
Form 4
| -2.87% | -95.00K |
$6.05 | -$574,750.00 | 3.21M |
Jan 14
| |||
Form 4
| -0.72% | -24.00K |
$6.30 | -$151,200.00 | 3.31M |
Jan 9
| |||
Form 4
| -26.26% | -1.19M |
$6.20 | -$7,359,400.00 | 3.33M |
Dec 31
| |||
Form 4
| -39.17% | -2.91M |
$7.69 | -$22,385,590.00 | 4.52M |
Oct 17
| |||
No matching records found |
IMMUNE DESIGN CORP. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -15.77% | -902.00K |
$1.83 | -$1,653,907.20 | 4.82M |
Dec 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Cascadian Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| -41.40% | -4.00M |
—
|
—
| 5.66M |
Feb 5
| |||
Form 4
| +4.08% | 378.44K |
$1.82 | $688,678.86 | 9.66M |
Dec 15 - Dec 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| -7.41% | -554.24K |
$3.24 | -$1,795,731.12 | 6.92M |
Jul 16
| |||
Form 4
| +1.76% | 129K |
$1.78 | $229,620.00 | 7.48M |
Nov 1
| |||
Form 4
| +3.64% | 258.36K |
$1.65 | $426,166.47 | 7.35M |
Aug 8
| |||
Form 4
| +5.01% | 338.09K |
$1.76 | $589,602.29 | 7.09M |
Jul 31 - Aug 1
| |||
Form 4
| +1.09% | 214.47K |
$1.79 | $387,225.99 | 19.95M |
Jun 5 - Jun 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |